Viewing Study NCT00100256


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-01-01 @ 8:05 AM
Study NCT ID: NCT00100256
Status: UNKNOWN
Last Update Posted: 2022-11-07
First Post: 2004-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Sponsor: Andarix Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-01
Start Date Type: None
Primary Completion Date: 2009-06-20
Primary Completion Date Type: ACTUAL
Completion Date: 2025-04-20
Completion Date Type: ESTIMATED
First Submit Date: 2004-12-27
First Submit QC Date: None
Study First Post Date: 2004-12-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-10-31
Last Update Post Date: 2022-11-07
Last Update Post Date Type: ACTUAL